You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced melanoma

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Beijing (TQB3811)

Recruiting
  • Solid Tumor
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Dec 2, 2021

Tumors, Breast, Tumors, Lung, Tumors,Colorectal Trial in Beijing, Tianjin, Hangzhou (ESG401)

Recruiting
  • Neoplasms, Breast
  • +5 more
  • Beijing, Beijing, China
  • +2 more
Sep 14, 2021

Within Minimally Invasive Surgery Short Title: Video Analysis in

Not yet recruiting
  • Prostate Cancer
  • Rectal Cancer
  • Video and kinematic data recording of minimally invasive surgical procedure
  • (no location specified)
Mar 14, 2022

Gastric Cancer Trial in Tai'an (Camrelizumab Combined with SOX)

Recruiting
  • Gastric Cancer
  • Camrelizumab Combined with SOX
  • Tai'an, Shandong, China
    The Second Affiliated Hospital of Shandong First Medical Univers
Dec 22, 2021

Advanced Solid Tumors and Hematological Malignancies Trial (TQB2928 Injection)

Not yet recruiting
  • Advanced Solid Tumors and Hematological Malignancies
  • TQB2928 Injection
  • (no location specified)
Apr 21, 2021

Colorectal Cancer, Immunotherapy, Anlotinib Trial in Shanghai (Anlotinib plus Sintilimab)

Recruiting
  • Colorectal Cancer
  • +5 more
  • Anlotinib plus Sintilimab
  • Shanghai, China
    Department of Medical Oncology, Shanghai Changzheng Hospital
Dec 28, 2020

Advanced Microsatellite Stable Colorectal Cancer, Metastatic Microsatellite-stable Colorectal Cancer Trial (Sintilimab,

Not yet recruiting
  • Advanced Microsatellite Stable Colorectal Cancer
  • Metastatic Microsatellite-stable Colorectal Cancer
  • (no location specified)
Feb 3, 2021

NSCLC, Radiation Therapy, Locally Advanced Disease Trial in Lyon (mid-position radiation strategy, ITV)

Completed
  • Non-small Cell Lung Cancer
  • +4 more
  • mid-position radiation strategy
  • ITV
  • Lyon, France
    Centre Léon Bérard
Feb 4, 2021

Familial Adenomatous Polyposis Trial in Worldwide (Eflornithine, Eflornithine Placebo, Sulindac 150 MG)

Completed
Has Results
  • Familial Adenomatous Polyposis
  • La Jolla, California
  • +16 more
May 12, 2021

Renal Cell Cancer Metastatic Trial in Beijing (CM082 combined with everolimus, CM082, Everolimus)

Unknown status
  • Renal Cell Cancer Metastatic
  • CM082 combined with everolimus
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Feb 4, 2021

Autonomic Nervous System Dysfunction in End-stage Kidney Disease

Recruiting
  • Kidney Failure, Chronic
    • Thessaloniki, Greece
      Department of Nephrology, Hippokration Hospital
    Mar 3, 2022

    Breast Cancer, HER2-negative Breast Cancer Trial in Canada, United States (Paclitaxel, Eribulin, Doxorubicin)

    Completed
    Has Results
    • Breast Cancer
    • HER2-negative Breast Cancer
    • Denver, Colorado
    • +19 more
    Oct 4, 2021

    Solid Tumor Trial in Richmond (Stereotactic radiotherapy, Biological: humanized anti-PD-1 mAb, Biological: humanized anti-PD-L1

    Completed
    Has Results
    • Solid Tumor
    • Stereotactic radiotherapy
    • +2 more
    • Richmond, Virginia
      Virginia Commonwealth University/Massey Cancer Center
    Dec 20, 2021

    Solid Tumor, Leukemia Trial in Paris (Solid tumor and CT DNA)

    Recruiting
    • Solid Tumor
    • Leukemia
    • Solid tumor and CT DNA
    • Paris, Villejuif, France
      Gustave Roussy
    Jan 19, 2023

    Melanoma Trial in Cambridge (Dabrafenib, Trametinib)

    Completed
    • Melanoma
    • Cambridge, England, United Kingdom
      Addenbrooke's Hospital
    Dec 4, 2020

    Solid Tumors Trial in Guangdong, Hangzhou (ICP-723)

    Recruiting
    • Solid Tumors
    • Guangdong, Guangzhou, China
    • +1 more
    Oct 20, 2021

    Life-limiting Cancer With Prognosis of Approximately 1 Year Trial in Ghent (Interventional palliative care, Standard oncologic

    Completed
    • Life-limiting Cancer With Prognosis of Approximately 1 Year
    • Interventional palliative care
    • Standard oncologic care
    • Ghent, Belgium
      Ghent University Hospital
    Nov 18, 2021

    Recurrent Melanoma, Stage III Skin Melanoma, Stage IV Skin Melanoma Trial in San Antonio (biological, other, drug)

    Completed
    Has Results
    • Recurrent Melanoma
    • +2 more
    • Bevacizumab
    • +3 more
    • San Antonio, Texas
      Cancer Therapy and Research Center at The UT Health Science Cent
    Oct 19, 2017

    Carcinoma, Hepatocellular Trial in Incheon, Seoul (Genexol-PM)

    Terminated
    • Carcinoma, Hepatocellular
    • Incheon, Korea, Republic of
    • +1 more
    Feb 2, 2021

    Hepatocellular Carcinoma by BCLC Stage Trial in Rennes (Tislelizumab)

    Not yet recruiting
    • Hepatocellular Carcinoma by BCLC Stage
    • Rennes, France
      Centre Eugene Marquis
    Jan 16, 2023

    NSCLC Trial in Ann Arbor (radiation, drug, device)

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Response-driven Adaptive Radiation Therapy
    • +5 more
    • Ann Arbor, Michigan
    • +1 more
    Dec 17, 2021

    Palliative Radiotherapy, Radiotherapy, Intensity-Modulated Trial in Saint Leonards (Radiation Therapy)

    Recruiting
    • Palliative Radiotherapy
    • Radiotherapy, Intensity-Modulated
    • Radiation Therapy
    • Saint Leonards, New South Wales, Australia
      Royal North Shore Hospital
    Jun 10, 2021

    Exhaled Breath Particles in Lung Cancer

    Recruiting
    • Lung Cancer
    • +3 more
    • EBPcollected using the PExA device.
    • Lund, Skåne Län, Sweden
      Skåne University Hospital
    May 24, 2022

    Child Behavior Disorders Trial in Darjeeling (Tealeaf-Mansik Swasta (Tealeaf), Enhanced Usual Care (EUC))

    Completed
    • Child Behavior Disorders
    • Tealeaf-Mansik Swasta (Tealeaf)
    • Enhanced Usual Care (EUC)
    • Darjeeling, West Bengal, India
      DLR Prerna
    Jan 12, 2023

    Tumor Trial in Chuo-Ku, Kashiwa (JNJ-63723283, Erdafitinib)

    Completed
    • Neoplasm
    • Chuo-Ku, Japan
    • +1 more
    Nov 3, 2022